Correlation Between Apogee Therapeutics, and Tarsus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apogee Therapeutics, Common and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Apogee Therapeutics, and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Tarsus Pharmaceuticals.

Diversification Opportunities for Apogee Therapeutics, and Tarsus Pharmaceuticals

-0.65

Correlation Coefficient

Apogee Therapeutics,  Tarsus Pharmaceuticals

Excellent diversification

The 3 months correlation between Apogee and Tarsus is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Tarsus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Tarsus Pharmaceuticals

Given the investment horizon of 90 days Apogee Therapeutics, is expected to generate 1.19 times less return on investment than Tarsus Pharmaceuticals. In addition to that, Apogee Therapeutics, is 2.19 times more volatile than Tarsus Pharmaceuticals. It trades about 0.1 of its total potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about 0.26 per unit of volatility. If you would invest  4,832  in Tarsus Pharmaceuticals on September 24, 2024 and sell it today you would earn a total of  609.00  from holding Tarsus Pharmaceuticals or generate 12.6% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Apogee Therapeutics, Common  vs.  Tarsus Pharmaceuticals

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Tarsus Pharmaceuticals

Risk-Adjusted Performance

24 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Apogee Therapeutics, and Tarsus Pharmaceuticals

The main advantage of trading using opposite Apogee Therapeutics, and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.

The idea behind Apogee Therapeutics, Common and Tarsus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.